- Chart
- Trade
- Markets
- Cryptocurrencies
- Crypto Screener
- Prices
- DeFi Coins
- Market Cap charts
- DeFi Market Cap charts
- Bitcoin
- XRP
- Ethereum
- Bitcoin Cash
- EOS
- Stellar
- Litecoin
- Bitcoin SV
- Tether
Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
- Currencies
- Stocks
- Earnings Calendar
- Stock Screener
- Large-cap
- Top gainers
- Top losers
- Most active
- Most volatile
- Overbought
- Oversold
- All-time high
- All-time low
- High-dividend
- Sector & Industry
Apple, Advanced Micro Devices Inc, Amazon Com Inc, Tesla, Inc, Netflix, Inc, Facebook Inc
- Indices
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
- Futures
- Bonds
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
- Sparks
- Daily news
- Cryptocurrencies
- Screeners
- Community
- More
Genocea Biosciences, Inc
GNCA
NASDAQ
NASDAQ
NASDAQ
GNCA Stock Chart
1) Long trend. 2) The price is on the support line. Open order for Buy 2.04 Target 2,60. This is not an investment recommendation.
GNCA is heading higher for 3 months now on increasing volume, and seems confirming another support level. Will take some, take-profit @ 5.50.
see easy and self explanatory boxes on chart for Entry, Exit and Stop loss zones. Never chase any stock. Not for any recommendation, Just an Idea. Like it >> Click 👍/comment, and follow. closed rest of IZEA for +152% in 18days from my previous posts.
128M Market Cap can show good results in near future. Q3 2020 EPS results IS better compare to Q2 and Q1 2020. Reward can be better compare to Risk. Institutional Buying also increased. Price can move 2 to 9 USD. Best
****COULD BE A GREAT MOVE IN THE DAYS TO SOME, AFTER VERY POSITIVE DATA FOR THEIR GEN-009 CANCER VACCINE****** Joseph Pantginis also upgraded the stock to $42 today, he states, “Valuation and risks to price target achievement. We reiterate our Buy rating and are increasing our price target to $42 from $5.75. The factors impacting our target change include: (1)...
*****HOT STOCK FRIDAY, KEEP ON THE RADAR FOR MAJOR CONTINUATION IN THE DAYS AND WEEKS TO COME.******** AVERAGE TARGET PRICE $25.67 AVERAGE RECOMMENDATION BUY COMPANY DETAILS Genocea is a biopharmaceutical company developing personalized cancer immunotherapies. Our unique ATLAS™ technology platform allows us to identify immunotherapy targets based on each...
Trying to understand what's positive about GNCA..
This is for a special friend of mine, scully, here you see the trigger of 23.6 4.93$. Next target 6.15$, 6.39$ :)))))))))))))))))))))))
GNCA Stock was up almost 400 pips today on heavy trading volume after the company reported positive efficacy data from a Phase 2 trial for its genital herpes treatment. It rallied until it exhausted itself at Oct 2014 multiple resistance area (7.75,8.25 respectively). Indicators are signaling a Pullback is imminent, prices could consolidate around these levels for...